Navigation Links
SMU chemist wins NSF early career award
Date:12/9/2008

DALLAS -- Southern Methodist University chemist Brent Sumerlin has earned a National Science Foundation Faculty Early Career Development Award, given to junior faculty members who exemplify the role of teacher-scholars in American colleges and universities.

Sumerlin, assistant professor in the Dedman College Department of Chemisty, will receive $475,000 over five years for two related nanotechnology research projects one with potential biomedical applications, and the other with a promising advanced materials application. The prestigious award also includes support for education outreach, and Sumerlin's will fund a program for K-12 school districts and community colleges to help prepare and attract underrepresented minority students for SMU chemistry internship positions.

"As a teacher, as a scientist, and through his community outreach and service, Professor Sumerlin exemplifies the finest scholarly tradition," said Cordelia Candelaria, dean of Dedman College of Humanities and Sciences. " His work is dedicated to expanding minds through exposure to basic science, including a generous willingness to share his lessons and labs off campus with teachers and students in elementary, middle and high school classrooms. Dedman College is thrilled by NSF's recognition of Brent's achievements."

Sumerlin, 32, works with an SMU team of postdoctoral research associates, graduate and undergraduate students who fuse the fields of polymer, organic and biochemistries to develop novel materials with composite properties. "This award enhances what I do at the university level and what I can do through SMU for the rest of the community," Sumerlin said.

The first part of Sumerlin's NSF-funded research will investigate how nano-scale polymer particles can be triggered to come apart in response to a chemical stimulus. One of the potential applications of the technology is an automatic treatment solution for diabetics one that would release insulin from tiny polymer spheres when they encounter dangerous levels of glucose in the bloodstream.

"Researchers worldwide are looking toward methods of insulin delivery that will relieve diabetics of frequent blood-sugar monitoring and injections," Sumerlin said.

The second aspect of the project involves making polymers with the ability to come apart and put themselves back together again a technique that Sumerlin believes can be used to construct materials that are self-repairing. "We could potentially think about coatings for airplane wings that are damaged by debris during flight," Sumerlin said. "After landing, we could quickly treat the coating, causing it to re-form itself."

Sumerlin received his doctorate from the University of Southern Mississippi in 2003, accepted a position as visiting assistant professor at Carnegie Mellon University for the next two years and joined SMU in 2005.


'/>"/>

Contact: Kim Cobb
cobbk@smu.edu
214-768-7654
Southern Methodist University
Source:Eurekalert

Related biology technology :

1. Argonne scientist to give the plenary talk at Royal Society of Chemistry meeting on nanoalloys
2. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development
3. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
4. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
5. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
6. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
7. BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology
8. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
9. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
10. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
11. For creating new field of science, Texas chemist wins international prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... ... February 20, 2017 , ... PuraCath Medical, ... with peritoneal dialysis, announced today that it has published the result of its ... Peritoneal Dialysis International (PDI), the official Journal of the International Society for ...
(Date:2/20/2017)... 20, 2017  Atrius Health and IBM (NYSE: ... agreement to develop a cloud based service designed ... holistic view of the multiple influences on an ... could be designed to support shared decision making ... innovative nonprofit healthcare organization with 875 physicians caring ...
(Date:2/18/2017)... Heights, IL (PRWEB) , ... February 17, 2017 ... ... for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood & ... Palms Convention Center in Orlando, Fla. , The combined scientific sessions ...
(Date:2/17/2017)... According to a new ... Service), Type (Safety, Efficacy, Validation), Disease Indication (Cancer, ... Development, Disease-Risk) - Global Forecast to 2021" published ... USD 53.34 Billion by 2021 from USD 27.95 ... 13.8% during the forecast period (2016-2021). ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 The biometrics ... by the confluence of organizations, desires to better ... knowledge-based systems (password and challenge questions), biometrics is ... government systems. The market is driven by use ... between consumer and enterprise uses cases, with consumer-facing ...
(Date:2/7/2017)... 7, 2017 Ipsidy Inc. ( ... [OTC: IDGS], ("Ipsidy" or the "Company") a provider of ... services, is pleased to announce the following changes as ... Effective January 31, 2017, Philip D. Beck ... and President.  An experienced payment industry professional and public ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
Breaking Biology News(10 mins):